Selenium Levels and Antioxidant Activity in Critically Ill Patients with Systemic Inflammatory Response Syndrome

dc.contributor.authorHerrera Quintana, Lourdes
dc.contributor.authorVázquez Lorente, Héctor
dc.contributor.authorMolina López, Jorge
dc.contributor.authorGamarra Morales, Yenifer
dc.contributor.authorPlanells, Elena
dc.date.accessioned2022-03-24T10:40:35Z
dc.date.available2022-03-24T10:40:35Z
dc.date.issued2022
dc.description.abstractThe Selenium (Se) status could be an important modifiable factor in critically ill patient outcomes due to the important role of this mineral in several functions. Although there are many clinical trials with Se interventions in the literature, the evidence is not sufficient to establish a common criterion regarding the Se status. Background and aims: An analysis was made of the evolution of selenium (Se) and antioxidant status in critically ill patients with Systemic Inflammatory Response Syndrome (SIRS) over 7 days of staying in the Intensive Care Unit (ICU). Methods: A prospective analytical study was carried out on 65 critically ill patients aged 31–77 years. A healthy control group of 56 volunteers from the same region was recruited to allow comparisons with reference normal values. The selenium levels in both the plasma and erythrocytes were analyzed by Inductively Coupled Plasma Mass Spectrometry (ICP-MS). Glutathione Peroxidase (GPx) and Superoxide Dismutase (SOD) activity and the Total Antioxidant Capacity (TAC) were measured using kinetic colorimetric methods. Results: Low erythrocyte and plasma Se levels were found at ICU admission in comparison with the healthy reference group (p < 0.001), and the levels further decreased after one week (p < 0.001). Smaller changes in the plasma Se levels were associated with greater changes in the Sequential Organ Failure Assessment (SOFA) score (p < 0.05). The GPx activity in the critically ill was lower than in the control group (p < 0.05), with an inverse correlation to the severity scores at the baseline (p < 0.05) and reaching normal values after one week (p < 0.05). SOD activity was directly correlated to TAC (p = 0.03), with both parameters exhibiting a direct correlation to albumin (p < 0.05) after 7 days of ICU stay. Conclusions: A deficient Se status was observed at ICU admission and worsened further over follow-up regardless of the evolution of the patient severity and the antioxidant parameters. Adequate Se support from the start of admission could preserve and contribute to improve the Se-related outcomes and critical patient recovery during longer periods in the ICUes_ES
dc.description.departmentDidácticas Integradas
dc.description.sponsorshipThis study received external funding from FIS projects of the Carlos III Health Institute [REF. PI10/1993] and FEDER Andalucía (REF. A-CTS-708-UGR20). L.H.-Q. (FPU2018/03655) and H.V.-L. (FPU2018/03702) are under an FPU fellowships from the Spanish Ministry of Education.
dc.identifier.citationHerrera-Quintana L, Vázquez-Lorente H, Molina-López J, Gamarra-Morales Y, Planells E. Selenium Levels and Antioxidant Activity in Critically Ill Patients with Systemic Inflammatory Response Syndrome. Metabolites. 2022; 12(4):274. https://doi.org/10.3390/metabo12040274es_ES
dc.identifier.doi10.3390/metabo12040274
dc.identifier.issn2218-1989 (electrónico)
dc.identifier.urihttp://hdl.handle.net/10272/20793
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.accessRightsopen accesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subject.otherSeleniumes_ES
dc.subject.otherAntioxidantes_ES
dc.subject.otherSeverityes_ES
dc.subject.otherCritically ill patientes_ES
dc.subject.otherIntensive care unites_ES
dc.subject.otherSystemic inflammatory response syndromees_ES
dc.titleSelenium Levels and Antioxidant Activity in Critically Ill Patients with Systemic Inflammatory Response Syndromees_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublicationea009046-5c35-4f3a-821e-ca10ad472f51
relation.isAuthorOfPublication.latestForDiscoveryea009046-5c35-4f3a-821e-ca10ad472f51

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
metabolites-12-00274.pdf
Size:
820.87 KB
Format:
Adobe Portable Document Format
Description:
Versión editor

Collections